文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Willingness to utilize supervised injection facilities among people who inject drugs in Iran: Findings from 2020 national HIV bio-behavioral surveillance survey.

作者信息

Khezri Mehrdad, Karamouzian Mohammad, Sharifi Hamid, Ghalekhani Nima, Tavakoli Fatemeh, Mehmandoost Soheil, Mehrabi Fatemeh, Pedarzadeh Marjan, Nejat Mehdi, Noroozi Alireza, Baral Stefan, Shokoohi Mostafa

机构信息

HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV, Surveillance Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.

HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV, Surveillance Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran; School of Population and Public Health, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.

出版信息

Int J Drug Policy. 2021 Nov;97:103355. doi: 10.1016/j.drugpo.2021.103355. Epub 2021 Jul 7.


DOI:10.1016/j.drugpo.2021.103355
PMID:34242959
Abstract

BACKGROUND: Supervised injection facilities (SIFs) have not yet been integrated into Iran's harm reduction programs. This study aimed to report the extent to which people who inject drugs (PWID) in Iran are willing to use SIFs. METHODS: Participants were recruited from 11 major cities using respondent-driven sampling. Willingness to use SIFs was defined as a three-level categorical variable: low, moderate, or high. RESULTS: Of 2,490 PWID, 52.8% and 23.8% reported high and moderate willingness to use SIFs, respectively. PWID with a history of homelessness (relative-risk ratio (RRR): 2.22, 95% CI: 1.76-2.80), incarceration (1.86 [1.48-2.35]), hepatitis C infection (1.49 [1.13-1.97]), and non-fatal overdose (2.30 [1.69-3.13]) were more likely to be willing to utilize SIFs. Willingness to use SIFs was also higher among PWID who reported recent public injecting (2.24 [1.70-2.97]), daily injection (1.82 [1.35-2.45]), stimulants injection (2.39 [1.41-4.07]), syringe sharing (3.09 [1.23-7.74]), harm reduction services utilization (2.80 [2.13-3.68]), and food insecurity (8.28 [5.43-12.63]). CONCLUSION: The majority of PWID in Iran expressed willingness to use SIFs, in particular, those who were involved in higher-risk injection practices, dealing with structural risks, and had experienced drug-related harms. SIFs represent critical opportunities to deliver comprehensive harm reduction services to improve the health and well-being of PWID in Iran.

摘要

相似文献

[1]
Willingness to utilize supervised injection facilities among people who inject drugs in Iran: Findings from 2020 national HIV bio-behavioral surveillance survey.

Int J Drug Policy. 2021-11

[2]
Acceptability of supervised injection facilities among persons who inject drugs in upstate New York.

Harm Reduct J. 2022-7-30

[3]
Public injecting and its association with mental health and other drug-related outcomes among people who inject drugs in Iran.

J Subst Abuse Treat. 2022-12

[4]
Awareness and willingness to use HIV self-testing among people who inject drugs in Iran.

Harm Reduct J. 2023-10-7

[5]
Perceptions about supervised injection facilities among people who inject drugs in Philadelphia.

Int J Drug Policy. 2017-12-10

[6]
Access to harm reduction programs among persons who inject drugs: findings from a respondent-driven sampling survey in Tehran, Iran.

Int J Drug Policy. 2014-7

[7]
Supervised injection facility use and all-cause mortality among people who inject drugs in Vancouver, Canada: A cohort study.

PLoS Med. 2019-11-26

[8]
Examining Overdose and Homelessness as Predictors of Willingness to Use Supervised Injection Facilities by Services Provided Among Persons Who Inject Drugs.

Am J Addict. 2021-1

[9]
Dual HIV risk and vulnerabilities among people who inject drugs in Iran: Findings from a nationwide study in 2020.

Harm Reduct J. 2024-10-18

[10]
HIV prevention cascades for injection and sexual risk behaviors among HIV-negative people who inject drug in Iran.

Int J Drug Policy. 2020-10

引用本文的文献

[1]
The prevalence of homelessness and its associated factors among people who inject drugs in Iran: results from nationwide bio-behavioral surveillance surveys in 2020 and 2023.

BMC Public Health. 2025-6-2

[2]
Correlates of duration between initial drug use and first drug injection among people who inject drugs in Iran, 2020.

BMC Public Health. 2025-4-1

[3]
Characterizing people who inject drugs with no history of opioid agonist therapy uptake in Iran: Results from a national bio-behavioural surveillance survey in 2020.

Int J Ment Health Addict. 2024-8

[4]
Dual HIV risk and vulnerabilities among people who inject drugs in Iran: Findings from a nationwide study in 2020.

Harm Reduct J. 2024-10-18

[5]
Sleep quality and associated factors among people who inject drugs in Iran: a nationwide survey using respondent-driven sampling.

BMC Public Health. 2024-8-5

[6]
Awareness and willingness to use HIV self-testing among people who inject drugs in Iran.

Harm Reduct J. 2023-10-7

[7]
HIV Continuum of Care Among People Who Inject Drugs in Iran: A Cross-sectional Study.

J Assoc Nurses AIDS Care. 2023

[8]
Hepatitis C virus prevalence, determinants, and cascade of care among people who inject drugs in Iran.

Drug Alcohol Depend. 2023-2-1

[9]
Epidemiology and spatial distribution of people diagnosed with HIV between 1997 and 2020 in Kerman, Iran.

Sex Transm Infect. 2023-3

[10]
HIV Prevalence and Related Behaviors Among People Who Inject Drugs in Iran from 2010 to 2020.

AIDS Behav. 2022-9

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索